Prosight Management »

Insmed shares owned by Prosight Management

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Prosight Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $40M 376k 106.62
2023-03-31 $449k 26k 17.05

More positions owned by Prosight Management

Lakefront Biotherapeutics Nv Spon Adr
Janux Therapeutics (JANX)
Nektar Therapeutics Com New (NKTR)
Boston Scientific Corporation (BSX)
Shattuck Labs (STTK)
Insmed Com Par $.01 (INSM)
Alnylam Pharmaceuticals (ALNY)
Syndax Pharmaceuticals (SNDX)
Kura Oncology (KURA)
Alkermes SHS (ALKS)
Irhythm Technologies (IRTC)
Veeva Sys Cl A Com (VEEV)
Zymeworks Del (ZYME)
Abivax Sa Sponsored Ads (ABVX)
Crinetics Pharmaceuticals In (CRNX)

View all positions for Prosight Management

Top funds holding Insmed

FMR
BlackRock
Jpmorgan Chase & Co
Vanguard Portfolio Management
Vanguard Capital Management
Baker Bros. Advisors
Capital Research and Management Company - Division 3
Darwin Global Management
Ameriprise Financial
Orbis Allan Gray
D. E. Shaw & Co
State Street Corporation
Artisan Partners Limited Partnership
Rtw Investments
Geode Capital Management

View all funds holding Insmed